PPP1R2C
gene geneOn this page
Also known as I-4
Summary
PPP1R2C (PPP1R2 family member C, HGNC:16324) is a protein-coding gene on chromosome Xp11.3, encoding Protein phosphatase inhibitor 2 family member C (O14990). Functions as a protein phosphatase inhibitor.
Predicted to enable protein phosphatase inhibitor activity. Predicted to be involved in intracellular signal transduction.
Source: NCBI Gene 80316 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 2 total
- MANE Select transcript:
NM_025210
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:16324 |
| Approved symbol | PPP1R2C |
| Name | PPP1R2 family member C |
| Location | Xp11.3 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | I-4 |
| Ensembl gene | ENSG00000102055 |
| Ensembl biotype | protein_coding |
| OMIM | 301017 |
| Entrez | 80316 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000378131
RefSeq mRNA: 1 — MANE Select: NM_025210
NM_025210
CCDS: CCDS87739
Canonical transcript exons
ENST00000378131 — 1 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001476370 | 42777366 | 42778163 |
Expression profiles
Bgee: expression breadth broad, 39 present calls, max score 95.26.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.0722 / max 62.7008, expressed in 8 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 198977 | 0.0722 | 8 |
Top tissues by expression
240 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| left testis | UBERON:0004533 | 95.26 | gold quality |
| right testis | UBERON:0004534 | 95.10 | gold quality |
| sperm | CL:0000019 | 93.56 | gold quality |
| male germ cell | CL:0000015 | 92.40 | gold quality |
| testis | UBERON:0000473 | 92.01 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 90.26 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 86.22 | gold quality |
| adult organism | UBERON:0007023 | 82.66 | gold quality |
| triceps brachii | UBERON:0001509 | 63.22 | gold quality |
| gluteal muscle | UBERON:0002000 | 63.16 | gold quality |
| buccal mucosa cell | CL:0002336 | 61.60 | gold quality |
| tongue squamous epithelium | UBERON:0006919 | 58.35 | gold quality |
| frontal pole | UBERON:0002795 | 56.66 | gold quality |
| tibia | UBERON:0000979 | 56.30 | gold quality |
| superficial temporal artery | UBERON:0001614 | 56.26 | gold quality |
| gingival epithelium | UBERON:0001949 | 53.14 | gold quality |
| paraflocculus | UBERON:0005351 | 52.28 | gold quality |
| endometrium epithelium | UBERON:0004811 | 52.19 | gold quality |
| parotid gland | UBERON:0001831 | 52.14 | gold quality |
| quadriceps femoris | UBERON:0001377 | 52.08 | gold quality |
| vastus lateralis | UBERON:0001379 | 51.40 | gold quality |
| parietal pleura | UBERON:0002400 | 51.26 | gold quality |
| pleura | UBERON:0000977 | 50.89 | gold quality |
| visceral pleura | UBERON:0002401 | 50.86 | gold quality |
| middle frontal gyrus | UBERON:0002702 | 50.30 | gold quality |
| Brodmann (1909) area 10 | UBERON:0013541 | 50.18 | gold quality |
| metanephric glomerulus | UBERON:0004736 | 49.61 | gold quality |
| myocardium | UBERON:0002349 | 49.55 | gold quality |
| deltoid | UBERON:0001476 | 49.51 | gold quality |
| Brodmann (1909) area 46 | UBERON:0006483 | 49.30 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 1.06 |
Regulation
Is transcription factor: no
Upstream regulators (CollecTRI, top): TP53
Literature-anchored findings (GeneRIF, showing 2)
- inhibitor-1beta consisted of 132 amino acids of which the N-terminal 61 amino acid sequences were identical to inhibitor-1 while the sequence after residue-61 was markedly different. (PMID:11883959)
- A streamlined nomenclature for human primary regulators of type-1 protein phosphatase (PP1) genes and pseudogenes is proposed. (PMID:11948623)
Cross-species orthologs
5 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | ENSMUSG00000121742 | |
| drosophila_melanogaster | I-2 | FBGN0028429 |
| drosophila_melanogaster | CG12620 | FBGN0032626 |
| drosophila_melanogaster | CG6380 | FBGN0032632 |
| caenorhabditis_elegans | WBGENE00021312 |
Paralogs (2): PPP1R2 (ENSG00000184203), PPP1R2B (ENSG00000231989)
Protein
Protein identifiers
Protein phosphatase inhibitor 2 family member C — O14990 (reviewed: O14990)
Alternative names: PPP1R2 family member B, Protein phosphatase 1, regulatory subunit 2 pseudogene 9, Type-1 protein phosphatase inhibitor 4
All UniProt accessions (1): O14990
UniProt curated annotations — full annotation on UniProt →
Function. Functions as a protein phosphatase inhibitor. It inhibits activity of the catalytic subunit of PP1 and weakly inhibits the activity of myosin-associated phosphates.
Tissue specificity. Detected in sperm (at protein level).
Similarity. Belongs to the protein phosphatase inhibitor 2 family.
RefSeq proteins (1): NP_079486* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR007062 | PPI-2 | Family |
Pfam: PF04979
UniProt features (10 total): region of interest 6, compositionally biased region 3, chain 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-O14990-F1 | 67.03 | 0.24 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 34 (showing top):
MODULE_99, GNF2_CCNA1, XU_GH1_EXOGENOUS_TARGETS_DN, GOMF_PHOSPHATASE_INHIBITOR_ACTIVITY, GOMF_ENZYME_INHIBITOR_ACTIVITY, GOMF_ENZYME_REGULATOR_ACTIVITY, GOMF_PHOSPHATASE_REGULATOR_ACTIVITY, RORA2_01, chrXp11, PURBEY_TARGETS_OF_CTBP1_NOT_SATB1_DN, GSE10463_CD40L_AND_VA347_VS_CD40L_IN_DC_DN, GSE13485_CTRL_VS_DAY21_YF17D_VACCINE_PBMC_DN, GSE13485_DAY3_VS_DAY21_YF17D_VACCINE_PBMC_DN, MYBL1_TARGET_GENES, GOMF_MOLECULAR_FUNCTION_INHIBITOR_ACTIVITY
GO Biological Process (2): regulation of signal transduction (GO:0009966), intracellular signal transduction (GO:0035556)
GO Molecular Function (2): protein phosphatase inhibitor activity (GO:0004864), protein binding (GO:0005515)
GO Cellular Component (0):
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| signal transduction | 2 |
| regulation of cell communication | 1 |
| regulation of signaling | 1 |
| regulation of response to stimulus | 1 |
| intracellular anatomical structure | 1 |
| phosphoprotein phosphatase activity | 1 |
| phosphatase inhibitor activity | 1 |
| protein phosphatase regulator activity | 1 |
| binding | 1 |
Protein interactions and networks
STRING
360 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| PPP1R2C | BRI3 | O95415 | 624 |
| PPP1R2C | CROCC2 | H7BZ55 | 447 |
| PPP1R2C | KRABD4 | Q5JUW0 | 437 |
| PPP1R2C | C16orf95 | Q9H693 | 435 |
| PPP1R2C | PPP1R12C | Q9BZL4 | 421 |
| PPP1R2C | SPANXN1 | Q5VSR9 | 416 |
| PPP1R2C | DUSP21 | Q9H596 | 406 |
| PPP1R2C | SPATA25 | Q9BR10 | 396 |
| PPP1R2C | CT47A11 | Q5JQC4 | 394 |
| PPP1R2C | C1orf174 | Q8IYL3 | 393 |
| PPP1R2C | PPP1R11 | O60927 | 377 |
| PPP1R2C | DIPK2B | Q9H7Y0 | 371 |
| PPP1R2C | ZNF674 | Q2M3X9 | 367 |
| PPP1R2C | EFHC2 | Q5JST6 | 357 |
| PPP1R2C | HAGHL | Q6PII5 | 350 |
IntAct
12 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| PPP1R2C | PPP1CC | psi-mi:“MI:0915”(physical association) | 0.560 |
| PPP1R2C | PPP1CA | psi-mi:“MI:0915”(physical association) | 0.560 |
| PPP1R2C | PPP1CB | psi-mi:“MI:0915”(physical association) | 0.560 |
| PPP1R2C | PPP1CA | psi-mi:“MI:0915”(physical association) | 0.000 |
| PPP1R2C | PPP1CB | psi-mi:“MI:0915”(physical association) | 0.000 |
ESM2 similar proteins: A0A1B0GV96, A0MZ66, A0MZ67, A2VDA9, A5PJI6, A6NKN8, A8R4Q8, E7F7X0, O14990, O19021, O42932, O62770, O62771, P13505, P36425, P48539, P54866, P63054, P63055, P84086, P84087, P84088, Q04504, Q0P561, Q148C4, Q15506, Q28IH8, Q3UYG8, Q4R615, Q5F3A1, Q5M8L3, Q5R4Q3, Q5ZM33, Q62252, Q62736, Q6DBA5, Q6GNQ4, Q6NWC9, Q6P3G4, Q6PUV4
Diamond homologs: O14990, P11845, P41236, P50411, Q3SZX2, Q4R615, Q6NXS1, Q96PQ5, Q9DCL8
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
2 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 0 |
| Likely benign | 2 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
0 predictions. Top by Δscore:
AlphaMissense
1326 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| X:42778039:A:G | I14T | 0.982 |
| X:42778032:T:A | K16N | 0.977 |
| X:42778032:T:G | K16N | 0.977 |
| X:42778044:C:A | K12N | 0.973 |
| X:42778044:C:G | K12N | 0.973 |
| X:42778033:T:A | K16I | 0.971 |
| X:42777941:A:G | W47R | 0.962 |
| X:42777941:A:T | W47R | 0.962 |
| X:42777939:C:A | W47C | 0.961 |
| X:42777939:C:G | W47C | 0.961 |
| X:42778043:C:G | G13R | 0.959 |
| X:42778043:C:T | G13R | 0.959 |
| X:42777669:G:C | F137L | 0.958 |
| X:42777669:G:T | F137L | 0.958 |
| X:42777671:A:G | F137L | 0.958 |
| X:42777657:T:A | R141S | 0.950 |
| X:42777657:T:G | R141S | 0.950 |
| X:42778033:T:G | K16T | 0.948 |
| X:42778034:T:C | K16E | 0.947 |
| X:42778039:A:C | I14S | 0.944 |
| X:42778042:C:T | G13E | 0.943 |
| X:42777676:C:G | R135P | 0.937 |
| X:42778036:A:G | L15P | 0.937 |
| X:42777620:C:G | A154P | 0.927 |
| X:42778043:C:A | G13W | 0.926 |
| X:42777615:T:A | R155S | 0.917 |
| X:42777615:T:G | R155S | 0.917 |
| X:42778046:T:C | K12E | 0.917 |
| X:42777619:G:T | A154D | 0.916 |
| X:42778036:A:T | L15Q | 0.916 |
dbSNP variants (sampled 300 via entrez): RS1000370132 (X:42778357 C>G,T), RS1000839077 (X:42778873 A>G), RS1001242599 (X:42777713 T>A), RS1001313904 (X:42779238 C>T), RS1002183735 (X:42779665 C>A), RS1002270923 (X:42779005 A>G), RS1003266409 (X:42777108 GTTACC>G), RS1004171007 (X:42778903 C>G), RS1004454441 (X:42779564 C>G,T), RS1005017476 (X:42779326 G>C,T), RS1005172079 (X:42777083 T>A,C), RS1005391171 (X:42777503 C>G,T), RS1005429319 (X:42778100 G>A), RS1009593299 (X:42778805 C>G,T), RS1009700277 (X:42778003 G>T)
Disease associations
OMIM: gene MIM:301017 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
3 total (human), top 3 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| CGP 52608 | affects binding, increases reaction | 1 |
| Benzo(a)pyrene | increases methylation | 1 |
| Valproic Acid | increases methylation | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.